Holen Sie sich die Stockscreener-App
59.60
3.45%
-2.13
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BMY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Bristol Myers Squibb Co Aktie (BMY) Neueste Nachrichten
Trust Co. of Toledo NA OH Sells 55,523 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Case-By-Case Guide As Justices Eye Landmark Pharma Law - Law360
Elkins, Bristol Myers Squibb CFO, sells $1.85 million in BMY stock - Investing.com Australia
Bristol-Myers Squibb Cancer Moves And Equity Efforts Underpin Valuation Case - Yahoo Finance UK
Growth and Income Portfolio's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Bristol-Myers Squibb Company (BMY) Options Chain - Yahoo! Finance Canada
Elkins, Bristol Myers Squibb CFO, sells $1.85 million in BMY stock By Investing.com - Investing.com South Africa
Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors - MarketWatch
Bristol-Myers Squibb Co (BMY) Shares Down 3.58% on Apr 2 - GuruFocus
Bristol Myers Squibb Cancer Pact And Equity Push Raise Valuation Questions - simplywall.st
Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.58% on Apr 2: What Signal Does It Send? - TradingKey
Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial of Camzyos - Insider Monkey
Ritter Alpha, LP's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Tema Etfs LLC Has $6.89 Million Holdings in Bristol Myers Squibb Company $BMY - marketbeat.com
20,914 Shares in Bristol Myers Squibb Company $BMY Acquired by J. Safra Sarasin Holding AG - marketbeat.com
F&V Capital Management LLC Boosts Holdings in Bristol Myers Squibb Company $BMY - marketbeat.com
Allspring Global Investments Holdings LLC Buys 67,783 Shares of Bristol Myers Squibb Company $BMY - marketbeat.com
DF Tactical Dividend Fund's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Janux announces development candidate nomination under Bristol Myers collab - tipranks.com
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day - MarketWatch
Bristol Myers Squibb Target of Unusually High Options Trading (NYSE:BMY) - marketbeat.com
Piramal Pharma Completes Acquisition of Kenalog Injectable Product from Bristol-Myers Squibb - scanx.trade
Bristol Myers Squibb (BMY) Partners with Janux on New Cancer The - GuruFocus
Janux Unveils Development Candidate in Bristol Myers Squibb Partnership, Worth $35M Milestone - Contract Pharma
Janux Therapeutics receives $35M milestone from Bristol Myers Squibb - Investing.com
Janux Therapeutics receives $35M milestone from Bristol Myers Squibb By Investing.com - Investing.com India
Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment - Yahoo Finance Singapore
Bristol Myers Squibb Company $BMY Shares Sold by Meyer Handelman Co. - marketbeat.com
Advanced Renal Cell Carcinoma Treatment Market to Grow by $3.1 Billion During 2026-2030: Global Industry Assessment Featuring Pfizer, Merck & Co., Bristol-Myers Squibb, AstraZeneca, Novartis and More - finance.yahoo.com
Bristol Myers Squibb Co. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Bristol Myers Squibb Discounts Sotyktu, Zeposia, Orencia SC on Government SiteNews and Statistics - indexbox.io
Bristol Myers Squibb Co. stock rises Tuesday, still underperforms market - MarketWatch
Bristol Myers Squibb Stock: Dividend Reliability and Pipeline Momentum Define Investor Appeal in 202 - AD HOC NEWS
Is Bristol Myers Squibb (BMY) Price Near US$60 Supported By Cash Flow And Earnings Models - simplywall.st
Kidney Cancer Drugs Market to Grow by $2 Billion During - globenewswire.com
Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry - Yahoo Finance
Ovarian Cancer Drugs Market Outlook Report 2026-2030 - GlobeNewswire
Ovarian Cancer Drugs Market Outlook Report 2026-2030 Featuring Strategic Analysis of AstraZeneca, Roche, Bristol-Myers Squibb Company, Clovis Oncology, Pfizer and Other Key Players - Yahoo Finance
Bristol Myers Squibb launches survey on myeloma care gaps By Investing.com - Investing.com India
Mn Services Vermogensbeheer B.V. Increases Stock Position in Bristol Myers Squibb Company $BMY - marketbeat.com
Retirement Systems of Alabama Boosts Position in Bristol Myers Squibb Company $BMY - marketbeat.com
Bristol Myers Squibb adding 3 medications on TrumpRx - Fox Business
Multiple Myeloma Market Is Going to Boom Rapidly | Bristol-Myers - openPR.com
Should You Buy Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming Dividend? - simplywall.st
Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed - GlobeNewswire Inc.
Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline - Yahoo Finance
Bristol-Myers Squibb Gets FDA Approval for Hodgkin’s Lymphoma Treatment - Insider Monkey
Jim Cramer on Bristol-Myers Squibb: “The stock’s recent pullbacks have represented terrific buying opportunities” - MSN
Is Bristol-Myers Squibb Company (BMY) A Good Stock To Buy Now? - Insider Monkey
Bristol Myers Squibb Stock: Strong Growth Portfolio and Dividend Yield Position BMY Shares as a Valu - AD HOC NEWS
Bristol Myers Squibb’s Camzyos shows promise in adolescent trial By Investing.com - Investing.com UK
Bristol Myers Squibb’s Camzyos shows promise in adolescent trial - Investing.com
Heart drug cuts blockage in teens with rare heart disease, trial shows - Stock Titan
A Look At Bristol Myers Squibb (BMY) Valuation As Growth Portfolio Outperforms Recent GAAP Loss - simplywall.st
Bristol-Myers Squibb (BMY) Faces Mixed Analyst Sentiment Despite Strong Momentum in Healthcare Industry - Insider Monkey
Wedge Capital Management L L P NC Decreases Stake in Bristol Myers Squibb Company $BMY - MarketBeat
Neuroscience data release drives Bristol-Myers Squibb stock lower 1.50% - tradersunion.com
BMY Stock Quote Price and Forecast - CNN
Bristol-Myers Squibb Co (MIL:1BMY) Bonds - GuruFocus
Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors - MarketWatch
Jim Cramer on Bristol-Myers Squibb: “The Stock’s Recent Pullbacks Have Represented Terrific Buying Opportunities” - Insider Monkey
Anti-Cancer MAbS Market Report 2026-2030 Featuring - globenewswire.com
Anti-Cancer MAbS Market Report 2026-2030 Featuring Strategic Analysis of Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, Roche, GlaxoSmithKline and Other Key Players - Yahoo Finance UK
Integras Partners LLC's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Global X Japan Co. Ltd. Raises Stock Position in Bristol Myers Squibb Company $BMY - marketbeat.com
Bristol-Myers Squibb Company Trade Ideas — BOATS:BMY - TradingView
0.81%
1.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):